Identifying non-tuberculosis mycobacteria: Is it time to introduce new molecular assays?

Affiliations

¹ National Health Laboratory Service, Green Point Laboratory, Cape Town, South Africa; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Christoffel.opperman@nhls.ac.za.
² City Health, Community Services and Health, City of Cape Town, South Africa. Christoffel.opperman@nhls.ac.za.
³ Division of Medical Microbiology, Institute of Infectious Disease and Molecular Medicine; and Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, South Africa. christoffel.opperman@nhls.ac.za.
⁴ DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. christoffel.opperman@nhls.ac.za.
⁵ DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Christoffel.opperman@nhls.ac.za.

Free article

C J Opperman et al. S Afr Med J. 2023.

Free article

. 2023 May 5;113(6):4-5.

doi: 10.7196/SAMJ.2022.v113i6.16771.

¹ National Health Laboratory Service, Green Point Laboratory, Cape Town, South Africa; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Christoffel.opperman@nhls.ac.za.
² City Health, Community Services and Health, City of Cape Town, South Africa. Christoffel.opperman@nhls.ac.za.
³ Division of Medical Microbiology, Institute of Infectious Disease and Molecular Medicine; and Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, South Africa. christoffel.opperman@nhls.ac.za.
⁴ DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. christoffel.opperman@nhls.ac.za.
⁵ DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Christoffel.opperman@nhls.ac.za.

No abstract available

MeSH terms